Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).
      QxMD      Google Scholar   
Citation:
Int J Radiat Oncol Biol Phys vol 106 (2) 255-60
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
9
Parents:
2756   3074  
Children:
None
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882; U10CA180790, U10CA180867, U10CA180863; U10CA180868; UG1CA189823  
Corr. Author:
 
Authors:
                                           
Networks:
CA249, LAPS-MA036, LAPS-MN026   
Study
Alliance-A151923
Multiple Studies, or Legacy Studies in Alliance Study:
NCCTG-N107C
Phases:
N/A, 3
Keywords: